Envestnet Asset Management’s Royalty Pharma RPRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.52M | Sell |
97,612
-6,250
| -6% | -$225K | ﹤0.01% | 2452 |
|
|
2025
Q1 | $3.23M | Buy |
103,862
+37,102
| +56% | +$1.15M | ﹤0.01% | 2422 |
|
|
2024
Q4 | $1.7M | Sell |
66,760
-763
| -1% | -$19.5K | ﹤0.01% | 2802 |
|
|
2024
Q3 | $1.91M | Sell |
67,523
-9,102
| -12% | -$257K | ﹤0.01% | 2688 |
|
|
2024
Q2 | $2.02M | Sell |
76,625
-12,114
| -14% | -$319K | ﹤0.01% | 2590 |
|
|
2024
Q1 | $2.7M | Buy |
88,739
+49,256
| +125% | +$1.5M | ﹤0.01% | 2381 |
|
|
2023
Q4 | $1.11M | Buy |
39,483
+18,139
| +85% | +$510K | ﹤0.01% | 2868 |
|
|
2023
Q3 | $579K | Buy |
21,344
+5,858
| +38% | +$159K | ﹤0.01% | 3171 |
|
|
2023
Q2 | $476K | Sell |
15,486
-339
| -2% | -$10.4K | ﹤0.01% | 3235 |
|
|
2023
Q1 | $570K | Buy |
15,825
+2,899
| +22% | +$104K | ﹤0.01% | 3052 |
|
|
2022
Q4 | $511K | Buy |
12,926
+428
| +3% | +$16.9K | ﹤0.01% | 3087 |
|
|
2022
Q3 | $502K | Buy |
12,498
+2,371
| +23% | +$95.2K | ﹤0.01% | 3019 |
|
|
2022
Q2 | $426K | Buy |
10,127
+1,603
| +19% | +$67.4K | ﹤0.01% | 3145 |
|
|
2022
Q1 | $332K | Buy |
8,524
+2,176
| +34% | +$84.8K | ﹤0.01% | 3389 |
|
|
2021
Q4 | $253K | Buy |
+6,348
| New | +$253K | ﹤0.01% | 3510 |
|